Skip to main content
Premium Trial:

Request an Annual Quote

Roy Davis

Clinical Genomics has appointed Roy Davis as a senior advisor and board member. Davis is currently a senior advisor for Huron Global Management Consulting and its Innosight subsidiary. He spent 27 years with Johnson & Johnson including separate stints as group president, company group chairman, worldwide franchise chairman, and president of J&J Development Corporation. Davis has also held managing director and general manager roles for Ortho Diagnostics in Europe, Japan, and the Americas. He was the founding president of Veridex, and has served as an innovations advisory board member for Cleveland Clinic.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.